STOCKHOLM, Oct. 18, 2021 /PRNewswire/ — Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, has through its fully owned subsidiary Mentice Inc entered into an agreement with ABBOTT Inc. to provide simulation solutions for training of interventional devices. The order covers systems that will be offered […]
Financial
CLEERLY APPOINTS JIM HARTMAN AS CHIEF REVENUE OFFICER
Sales strategy expert brings industry success to leverage growth. NEW YORK – October 18, 2021 – Cleerly, the company creating a new standard of care for heart disease, announced today it has appointed Jim Hartman as Chief Revenue Officer. In this role, Jim will be responsible for driving the company’s […]
OneProjects Announces $17 Million in New Financing to Advance Development of 4D Cardiac Imaging Technology
DUBLIN & MUNICH–(BUSINESS WIRE)–OneProjects, developer of four-dimensional (4D) cardiac imaging technology, today announced a total of $17 million in new financing for the company, including an $8 million Series A2 financing and two grants worth $9 million. The Series A2 financing was led by imec.xpand, with participation from the European […]
Abcentra Appoints Entrepreneur and Cardiologist Michael H. Davidson to Board of Directors
LOS ANGELES, Oct. 14, 2021 /PRNewswire/ — Abcentra LLC announced today that Michael H. Davidson, MD, has been appointed to the Board of Directors. Dr. Davidson is currently CEO of New Amsterdam Pharma, and was previously the founding CEO and Chief Medical Officer of Corvidia Therapeutics, which was acquired by Novo-Nordisk in 2020. He also co-founded […]
CytoSorbents Provides Preliminary Third Quarter Business Update and Revised 2021 Product Revenue Guidance
Preliminary third quarter 2021 total revenue was $9.7 million, including product sales of $8.9 million. Preliminary core non-COVID-19 product sales increased 4% Y-Y to approximately $7.8 million. MONMOUTH JUNCTION, N.J., Oct. 12, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood […]
Zynex Announces 70% Order Growth and Increases Q3 2021 Adjusted EBITDA Estimate Zynex
ENGLEWOOD, Colo., Oct. 13, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased Adjusted EBITDA estimate for Q3 2021. Thomas Sandgaard, CEO of Zynex said: “Our order […]
iRhythm® Technologies Announces Changes to Its Board of Directors
Karen Ling Appointed to the Board; Raymond Scott to Retire SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the appointment of Karen Ling, an experienced HR leader, to its […]
Vifor Pharma announces changes to its Executive Committee
Executive committee members Lee Heeson and Gregory Oakes to leave the company for personal reasons Succession planning ongoing AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group today announced changes to its Executive Committee as current members Lee Heeson, President International, and Gregory Oakes, President North America, have […]
physIQ Expands Leadership Team to Advance Digital Health Innovation and Strategic Global Growth
CHICAGO–(BUSINESS WIRE)–A leader in digital medicine, physIQ today announced the hiring of Gary Manning as Senior Vice President and General Manager of Healthcare Delivery, and John Varaklis as Chief Strategy Officer. Both new hires play a critical role in the company’s expansion strategy and reflect its commitment to providing solutions to healthcare […]
Boston Scientific Corporation to acquire Baylis Medical Company
Baylis Medical Technologies to increase investment in radiology and neurosurgery business in Canada MISSISSAUGA, Ont. (October 6, 2021) – Baylis Medical Company Inc. is pleased to announce it has reached an agreement to sell its cardiology business to Boston Scientific Corporation. The acquisition, for an upfront payment of $1.75 billion […]



